Biomarkers of NSCLC

 The implementation of molecular biomarkers in routine practice continues to be challenging. First, physicians must know which biomarkers should be analyzed in routine practice and be aware that additional markers may soon become standard. In this context, regularly updated guidelines can support physicians in their decisions. Nevertheless, clinical implementation of molecular biomarkers may differ among regions based on prevalence of the biomarker, availability of test methods, and access to corresponding treatments.

 

  • Aptahistochemistry for Identification of Lung Cancer Biomarkers
  • Biomarkers of Different Histological Lung Cancer Types
  • Biomarkers of Lung Cancer
  • Conventional Protein Biomarkers of Lung Cancer

Related Conference of Biomarkers of NSCLC

March 30-31, 2026

26th World Congress on Cancer and Diagnostics

London, UK
June 15-16, 2026

10th Global Meeting on Oncology and Radiology

Paris, France
June 22-23, 2026

16th World Congress on Breast Cancer

Dubai, UAE
June 23-24, 2026

27th World Congress on Cancer Summit

Paris, France
July 27-28, 2026

6th World Congress on Breast Cancer

Rome, Italy
September 28-29, 2026

36th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
October 05-06, 2026

22nd International Conference on Cancer Research

Madrid, Spain
November 19-20, 2026

44th World Cancer Conference

Dubai, UAE
November 23-24, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
November 23-24, 2026

8th International Conference on Women Oncology

Miami, USA
December 08-09, 2026

14th Euro Breast Cancer and Therapeutics

Paris, France

Biomarkers of NSCLC Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in